지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.7
- 수록면
- 767 - 781 (15page)
- DOI
- 10.4143/crt.2021.651
이용수
초록· 키워드
오류제보하기
PurposeHeat shock protein-90 (HSP90) remains an important cancer target because of its involvement in multiple oncogenic protein pathways and biologic processes. Although many HSP90 inhibitors have been tested in the treatment of KRAS-mutant non?small cell lung cancer (NSCLC), most, including AUY922, have failed due to toxic effects and resistance generation, even though a modest efficacy has been observed for these drugs in clinical trials. In our present study, we investigated the novel mechanism of resistance to AUY922 to explore possible avenues of overcoming and want to provide some insights that may assist with the future development of successful next-generation HSP90 inhibitors.Materials and MethodsWe established two AUY922-resistant KRAS-mutated NSCLC cells and conducted RNA sequencing to identify novel resistance biomarker.ResultsWe identified novel two resistance biomarkers. We observed that both integrin Av (ITGAv) and β3 (ITGB3) induce AUY922-resistance via focal adhesion kinase (FAK) activation, as well as an epithelial-mesenchymal transition, in both <i>in vitro</i> and <i>in vivo</i> xenograft model. mRNAs of both ITGAv and ITGB3 were also found to be elevated in a patient who had shown acquired resistance in a clinical trial of AUY922. ITGAv was induced by miR-142 downregulation, and ITGB3 was increased by miR-150 downregulation during the development of AUY922-resistance. Therefore, miR-150 and miR-142 overexpression effectively inhibited ITGAvB3-dependent FAK activation, restoring sensitivity to AUY922.ConclusionThe synergistic co-targeting of FAK and HSP90 attenuated the growth of ITGAvB3-induced AUY922-resistant KRAS-mutated NSCLC cells <i>in vitro</i> and <i>in vivo</i>, suggesting that this combination may overcome acquired AUY922-resistance in KRAS-mutant NSCLC.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
Cancer Research and Treatment
2020 .01
-
Mutational analysis of KRAS and its clinical implications in cervical cancer patients
Journal of Gynecologic Oncology
2018 .01
-
KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
Journal of Korean Medical Science
2016 .01
-
Evaluation of KRAS Gene Mutations in Metastatic Colorectal Cancer Patients in Kermanshah Province
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Prognostic Role of KRAS mRNA Expression in Breast Cancer
Journal of Breast Cancer
2019 .01
-
Can the presence of KRAS mutations guide the type of liver resection during simultaneous resection of colorectal liver metastasis?
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .05
-
EGFR targeting antibody of GC1118 effects in Colorectal cancer with KRAS mutation
한국실험동물학회 학술발표대회 논문집
2016 .02
-
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
Biomolecules & Therapeutics(구 응용약물학회지)
2019 .01
-
Studies on the Mechanism of HSP90 Inhibitors in Colorectal Cancer
대한외과학회 학술대회 초록집
2018 .11
-
KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay
Journal of Pathology and Translational Medicine
2017 .01
-
Association of KRAS Mutant Dosage with Survival and Recurrence in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma
대한외과학회 학술대회 초록집
2023 .05
-
Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
Journal of Pathology and Translational Medicine
2016 .01
-
Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)
Journal of Pathology and Translational Medicine
2018 .01
-
p16 Hypermethylation and KRASMutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
Cancer Research and Treatment
2016 .01
-
The Role of Brain Radiotherapy Before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer
Cancer Research and Treatment
2023 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0